Riskpilot← Back to searchSign inGet full accessNordaesth AB
ABActiveOrg 5592596968Kammakargatan 66Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20200 employees
Revenue 2025
SEK 650K
+43% vs 2024
EBITDA margin
-1.8%
-115% vs 2024
Equity ratio
69.4%
Financial strength
Net profit 2025
SEK -10K
-118% vs 2024
| Revenue | SEK 650K | +43% |
| EBITDA | SEK -12K | -115% |
| Net profit | SEK -10K | -118% |
| Total assets | SEK 115K | -75% |
| Equity | SEK 80K | -11% |
| Employees | 0 | — |
Legal name
Nordaesth AB
Org number
5592596968
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
15 juni 2020
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Verksamheten skall bedriva distribution och utbildning av läkemedels- och medicintekniska produkter.
Address
Kammakargatan 66
Email
christian.mortel@svenskahudkliniker.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 454 | 650 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −7 | −5 | −28 | 76 | −12 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | −7 | −5 | −28 | 76 | −12 |
| Net financials | — | — | −1 | −2 | 1 |
| Profit before tax | −7 | −5 | 18 | 74 | −10 |
| Tax | −0 | −0 | — | −15 | — |
| Net profit | −7 | −5 | 18 | 59 | −10 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 28 | 24 | 50 | 461 | 115 |
| Equity | 18 | 13 | 31 | 90 | 80 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 10 | 11 | 19 | 371 | 35 |
| Total debt | 10 | 11 | 19 | 371 | 35 |
EBITDA margin
-1.8%
This company
15.8%
Market median
-111% vs market
20212025
Equity ratio
69.4%
This company
38.2%
Market median
+82% vs market
20212025
Return on equity
-13.0%
This company
18.4%
Market median
-171% vs market
20212025
Net profit margin
-1.6%
This company
8.1%
Market median
-120% vs market
20212025
Asset turnover
5.66×
This company
1.12×
Market median
+405% vs market
20212025
Debt / equity
0.44×
This company
0.62×
Market median
+29% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
LM Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (5) | ||
| Board of Directors | 2020 | |
| Board of Directors | 2020 | |
| Chairman | 2022 | |
| Deputy Board Member | 2020 | |
| Deputy Board Member | 2020 | |
| Former (3) | ||
| Board of Directors | 2020 – 2022 | |
| Deputy Board Member | 2020 – 2022 | |
| Deputy Board Member | 2020 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
CMKM Holding AB
Nordaesth AB Board members of Nordaesth AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lene Meldgaard Pedersen | Chief Executive Officer | 0 companies |
| Bo Daniel Falk | Board of Directors | 0 companies |
| Anna Catarina S Reutercrona | Board of Directors | 0 companies |
| Kathrin Petra Mörtel | Board of Directors | 0 companies |
| C S Christian R M Mörtel | Chairman | 0 companies |
| Mari Sinikka Kovaniemi Feldt | Deputy Board Member | 0 companies |
| Frida Kathrin Mörtel | Deputy Board Member | 0 companies |
| Eva Cathrine Arnfridsdotter | Deputy Board Member | 0 companies |
| Carl Miles Niclas Reutercrona | Deputy Board Member | 0 companies |